Evidence map›Paper›PMID 40425278›Full record

ArticleCancer science2025

Diversity of U1 Small Nuclear RNAs and Diagnostic Methods for Their Mutations.

Takuma Nakashima, Tsubasa Miyauchi, Ryota Takeuchi, Yuriko Sugihara, Yusuke Funakoshi, Fumiharu Ohka, Sachi Maeda, Junko Hirato, Takako Yoshioka, Hajime Okita and 6 more

Abstract read
In one paragraph

Article in Cancer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Takuma NakashimaDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo City, Japan.ORCID https://orcid.org/0000-0002-5198-3516
Tsubasa MiyauchiDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo City, Japan.
Ryota TakeuchiIn Vitro Diagnostics Business, KYORIN Pharmaceutical Co., Ltd, Tokyo, Japan.
Yuriko SugiharaDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo City, Japan.
Yusuke FunakoshiDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo City, Japan.ORCID https://orcid.org/0000-0002-3039-2370
Fumiharu OhkaDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-5569-5626
Sachi MaedaDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Junko HiratoDepartment of Pathology, Public Tomioka General Hospital, Tomioka, Japan.
Takako YoshiokaDepartment of Pathology, National Center for Child Health and Development, Setagaya, Japan.
Hajime OkitaDivision of Diagnostic Pathology, Keio University School of Medicine, Minato City, Japan.
Yoshitaka NaritaDepartment of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo City, Japan.
Yonehiro KanemuraDepartment of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.
Yasuhiro KojimaLaboratory of Computational Life Science, National Cancer Center Research Institute, Tokyo, Japan.
Yuko WatanabeDepartment of Pediatric Oncology, National Cancer Center Hospital, Chuo City, Japan.
Ryuta SaitoDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan.
Hiromichi SuzukiDivision of Brain Tumor Translational Research, National Cancer Center Research Institute, Chuo City, Japan.

Funding

Astellas Foundation for Research on Metabolic DisordersAuthorized NPO (Non Profit Organization) Gold Ribbon NetworkCell Science Research FoundationJapan Agency for Medical Research and Development 22ck0106693h0002Japan Agency for Medical Research and Development 23ama221525h00Japan Agency for Medical Research and Development 23ck0106877h0001Japan Health Research Promotion Bureau 2024-D-01Japan Science and Technology Agency JST FOREST Program JPMJFR210QJapan Society for the Promotion of Science 21K21001Japan Society for the Promotion of Science 22H03190Japan Society for the Promotion of Science 22K19591Kobayashi Foundation for Cancer ResearchMSD Life Science Foundation, Public Interest Incorporated FoundationNational Cancer Center JapanTakeda Science FoundationUehara Memorial Foundation
6 · The paper itself

Abstract

U1 small nuclear RNA (snRNA) mutations are recurrent non-coding alterations found in various malignancies, yet their identification has proven challenging due to their repetitive nature. We characterized the complex interindividual diversity and genomic architecture of U1 snRNA loci using sequencing data and a pangenome reference. Our analysis uncovered copy number variations and the diversity of single-nucleotide variants in regions not predicted to have significant functional impact. Compared to traditional linear reference-based analyses for mutations, the pangenome graph demonstrated the best accuracy, successfully identifying previously undetectable mutations. This underscores the utility of pangenome graph references for cancer genome research, particularly in repetitive and highly diverse genomic regions. Additionally, we developed mutation detection methods employing targeted capture sequencing, rapid quantitative polymerase chain reaction, and a machine learning approach based on splicing patterns, all exhibiting high precision in identifying U1 snRNA mutations. Our findings elucidate the structural complexity of U1 snRNA loci and establish robust methodologies for precise mutation detection in these regions.

Indexed as

MutationNeoplasmsRNA, Small NuclearDNA Copy Number VariationsDNA Mutational AnalysisHumansMachine LearningPolymorphism, Single NucleotideRNA, Small NuclearU1 small nuclear RNAdiagnostic methodsgraph genomemedulloblastomapangenome referencesegmental duplications

Identifiers

PMID40425278
PMCPMC12317402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.